Targeting the life sciences market, DHL Global Forwarding has opened a new $1.6m facility in Indianapolis in the US. The building offers bonded services and three temperature controlled chambers: 15-25 degrees celsius storage and handling, 2-8 degrees celsius storage and handling and -20 degrees celsius storage and handling. Together the temperature controlled areas measure close to 20,000 sq ft and will be able to process pharmaceutical, biotech or medical devices that require a temperature-controlled environment.
“This new building is especially important now during these challenging times, when temperature controlled logistics is crucial in helping customers navigate the pandemic,” said David Goldberg, Chief Executive, DHL Global Forwarding, US.